These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 15752287)
1. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation. Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 protein in basal cell carcinomas of human skin. Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467 [TBL] [Abstract][Full Text] [Related]
4. bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Wikonkal NM; Berg RJ; van Haselen CW; Horkay I; Remenyik E; Begany A; Hunyadi J; van Vloten WA; de Gruijl FR Arch Dermatol; 1997 May; 133(5):599-602. PubMed ID: 9158413 [TBL] [Abstract][Full Text] [Related]
5. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474 [TBL] [Abstract][Full Text] [Related]
6. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies. Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330 [TBL] [Abstract][Full Text] [Related]
7. Roles of the transcription factor p53 in keratinocyte carcinomas. Brash DE Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710 [TBL] [Abstract][Full Text] [Related]
8. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion. Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432 [TBL] [Abstract][Full Text] [Related]
12. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270 [TBL] [Abstract][Full Text] [Related]
14. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Nagano T; Ueda M; Ichihashi M Arch Dermatol; 1993 Sep; 129(9):1157-61. PubMed ID: 8363400 [TBL] [Abstract][Full Text] [Related]
15. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120 [TBL] [Abstract][Full Text] [Related]
16. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208 [TBL] [Abstract][Full Text] [Related]
17. Sunburn and p53 in the onset of skin cancer. Ziegler A; Jonason AS; Leffell DJ; Simon JA; Sharma HW; Kimmelman J; Remington L; Jacks T; Brash DE Nature; 1994 Dec 22-29; 372(6508):773-6. PubMed ID: 7997263 [TBL] [Abstract][Full Text] [Related]
18. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450 [TBL] [Abstract][Full Text] [Related]
19. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709 [TBL] [Abstract][Full Text] [Related]
20. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]